Introduction
============

Posterior-capsule opacification (PCO) is a well documented postoperative complication of modern cataract surgery, and although rates have reduced since the days of extracapsular cataract extraction, it is still the most common cause of decreased visual acuity and loss of contrast sensitivity following surgery.[@b1-opth-7-1661],[@b2-opth-7-1661] PCO develops as a result of metaplasia and migration of residual lens epithelial cells (LECs) from the equator of the capsular bag, causing development of an opaque membrane across the posterior capsule.[@b1-opth-7-1661] Definitive treatment in the form of neodymium-doped yttrium aluminum garnet (Nd:YAG) laser posterior capsulotomy (LPC) is a quick and relatively easy outpatient procedure, although there are rare but significant complications associated with this treatment, including cystoid macular edema, retinal detachment, and raised intraocular pressure.[@b3-opth-7-1661]

The purpose of this study was to assess differences in postoperative LPC rates between patients receiving the older three-piece Hoya FY60AD intraocular lens (IOL) with the newer, sharper, square-edged three-piece Hoya PY60AD model following a change in manufacturing process aimed at reducing PCO development and the need for LPC. We also compared them with the commonly used one-piece AcrySof SN60WF IOL (Alcon Laboratories, Fort Worth, TX, USA).

Materials and methods
=====================

This retrospective study was registered with the Clinical Governance Department at Wye Valley NHS Trust, Hereford, UK. Patients undergoing cataract surgery and IOL implantation under a single consultant (JMAS) were included if they had undergone surgery over a 3-year period, representing a time of transition between the older Hoya FY60AD IOL and the newer PY60AD IOL, with the AcrySof SN60WF IOL also in routine use. Patients were excluded if the surgery was complicated by posterior-capsule rupture, vitreous loss, or IOL not fixated within the capsular bag, or if they required a combined procedure, such as indirect laser photocoagulation or intraocular injection of corticosteroid for diabetic retinopathy. Surgery was performed or directly supervised by AS, according to a standard approach under sub-Tenon's anesthesia. Clear corneal incision and side-port paracentesis were made, and viscoelastic (Healon, Abbott Medical Optics, Santa Ana, CA, USA) was used to inflate the anterior chamber. Continuous curvilinear capsulorhexis (CCC) was performed with a cystotome, followed by hydrodissection and phacoemulsification with a "divide-and-conquer" technique. Cortical lens matter was removed with automated coaxial irrigation/aspiration, followed by viscoelastic to inflate the capsular bag prior to insertion of the IOL. The viscoelastic was removed during completion of the surgery.

Characteristics of the three IOL models implanted are summarized in [Table 1](#t1-opth-7-1661){ref-type="table"}. The FY60AD and PY60AD have a 360° square-edge profile, although the edge of the latter is sharper than the former.[@b4-opth-7-1661] The AcrySof SN60WF has a square edge that is interrupted at the optic--haptic junction, and sharpness of the square edge lies between that of the two Hoya models ([Table 1](#t1-opth-7-1661){ref-type="table"}).[@b4-opth-7-1661]

Patients from this surgical cohort who subsequently underwent LPC within 2 years postoperatively were identified from the departmental laser clinic logbook. LPC was performed based on subjective patient complaints or measurable decrease in visual acuity, with concomitant clinical evidence of PCO on dilated examination with slit-lamp biomicroscopy. Details of the laser treatment were recorded for each patient.

The primary comparison was of LPC rates between the older Hoya FY60AD and the newer PY60AD IOLs. A secondary comparison was between the PY60AD and the Alcon SN60WF IOL. LPC rates between groups receiving the different IOLs were compared by Chi-squared analysis. Comparison between groups of other variables, including patient age, corrected distance visual acuity (CDVA), duration between primary surgery and subsequent LPC, and laser energy delivered was undertaken by analysis of variance using SPSS version 19 (IBM, Armonk, NY, USA). Statistical significance was reported at the *P* \< 0.05 level.

Results
=======

A total of 1,265 cataract operations were included. Average age was 72.3 (range 52--88) years at the time of surgery, with mean (± standard deviation) preoperative CDVA of 0.52 ± 0.32 logarithm of minimum angle of resolution (logMAR; approximately 6/19 Snellen) and postoperative CDVA 0.24 ± 0.19 logMAR (approximately 6/10 Snellen). Overall, 49 (3.9%) patients subsequently received LPC within 2 years of cataract surgery, on average 16.4 (range 10--24) months postoperatively. LPC rates for each IOL type are presented in [Table 2](#t2-opth-7-1661){ref-type="table"} and [Figure 1](#f1-opth-7-1661){ref-type="fig"}.

The average duration between cataract surgery and LPC was 15.8 ± 4.6 (range 8--24) months for patients receiving the FY60AD, 17.2 ± 4.3 (range 10--23) months for the PY60AD, and 17.1 ± 3.1 (range 13--22) months for the SN60WF ([Table 3](#t3-opth-7-1661){ref-type="table"}). The trend toward earlier LPC in the FY60AD group did not reach significance (*P* = 0.56). There were no significant differences between IOL groups for patient age, CDVA at the time of LPC, or amount of laser energy required ([Table 3](#t3-opth-7-1661){ref-type="table"}).

Discussion
==========

We report that the newer, sharper-edged Hoya PY60AD IOL had a significantly lower LPC rate compared to the older, rounder-edged Hoya FY60AD IOL, a reduction of 52% at 2 years postoperatively. Furthermore, the AcrySof SN60WF had a significantly lower rate than the Hoya PY60AD model. There was a trend toward earlier LPC requirement in the FY60AD group, although this did not reach statistical significance.

Whilst patient variables may influence the development of PCO and subsequent requirement for LPC, such as younger age, female sex, and ocular comorbidity, preventive strategies include variations in surgical technique, such as meticulous cortical cleanup, CCC in contact with the anterior surface of the IOL optic, posterior-capsule polishing, and placement of the IOL in the capsular bag.[@b5-opth-7-1661],[@b6-opth-7-1661] Hydrophilic IOLs are associated with higher rates of PCO and greater PCO severity than hydrophobic IOLs, acrylic IOLs are associated with less PCO formation than other biomaterials,[@b7-opth-7-1661]--[@b11-opth-7-1661] and LPC rates are reportedly lower in eyes implanted with aspheric compared to spherical IOLs.[@b12-opth-7-1661]

The importance of IOL-edge structure is widely accepted, and the evidence in favor of a square posterior optic edge in reducing PCO and LPC requirement is overwhelming. A square edge on the posterior IOL surface provides a barrier to LEC migration by inducing a capsular bend where it is in contact with the IOL edge.[@b13-opth-7-1661]--[@b17-opth-7-1661] A recent systematic review found significantly lower PCO scores in sharp-edged IOLs compared to round-edged models, although no clear differences between IOL materials.[@b18-opth-7-1661] However, not all square edges are the same, as edge sharpness is subject to variation between IOL models. Using scanning electron microscopy and computer-aided imaging, it is possible to determine the area of the lateral-posterior IOL edge deviating from a perfect square, demonstrating a large variation both between IOL designs and between different powers of the same design ([Figure 2](#f2-opth-7-1661){ref-type="fig"}). Area-measurement values for hydrophilic acrylic IOLs as a group are higher than for hydrophobic acrylic or silicone IOLs, indicating a more rounded edge in the former and suggesting that differences reported between IOL materials may actually be related in part to IOL-edge sharpness.[@b4-opth-7-1661],[@b19-opth-7-1661] In addition, a prospective, single surgeon, fellow-eye comparison study found higher PCO rates and poorer visual acuity with the Hoya AF-1 YA-60BB IOL compared to the Alcon AcrySof SN60AT, and electron microscopy showed a much sharper posterior-edge profile in the Alcon IOL compared to the Hoya IOL.[@b20-opth-7-1661] This type of evaluation can help manufacturers optimize their IOL optic edges. For example, Hoya Surgical Optics have recently altered their IOL-polishing process in order to sharpen the posterior edge of their IOLs, reducing the area of deviation from a perfect square from 329.7 μm^2^ in the older FY60AD model to a sharper 39.1 μm^2^ in the newer PY60AD and 251 IOLs, the latter now amongst the sharpest square-edge profiles of any commercially available IOL.[@b19-opth-7-1661] Our study supports the validity of this approach, with fewer patients requiring LPC after implantation with the sharper-edged PY60AD compared to the older FY60AD by 2 years after surgery.

The one-piece AcrySof IOL had superior results over the Hoya models, despite the edge of the former being less sharp than the newer Hoya PY60AD IOL. In addition, the posterior square edge of the AcrySof IOL optic is interrupted at the optic--haptic junction. This feature of most single-piece IOLs has been shown to be a factor in the development of PCO, as this point provides an opportunity for uninhibited LEC migration across the posterior capsule.[@b21-opth-7-1661],[@b22-opth-7-1661] However, studies have consistently failed to reach a consensus on the relative merits of one-piece versus three-piece IOLs per se in protecting against PCO development. Animal models and cadaveric studies report more PCO in eyes implanted with one-piece IOLs compared to three-piece models, with the optic--haptic junction as the primary site of initiation of PCO development.[@b7-opth-7-1661],[@b22-opth-7-1661],[@b23-opth-7-1661] Some clinical trials support this notion, eg, a retrospective review of 434 eyes implanted with either one-piece or three-piece AcrySof IOLs found a greater incidence of LPC at 24 months in the one-piece group (7.5%) compared to the three-piece group (3.6%).[@b5-opth-7-1661] The thin haptics of the three-piece IOL reportedly allow for better adhesion between the anterior and posterior capsules and bend formation, compared to the bulky haptics of one-piece models, which enable enhanced posterior LEC migration. However, two systematic reviews showed no significant differences in PCO intensity or laser-treatment rates between one- and three-piece IOLs.[@b24-opth-7-1661],[@b25-opth-7-1661] Extending the posterior square edge across the optic--haptic junction to create a 360° sharp edge in one-piece IOLs reduces PCO development and LPC rates compared to single piece IOLs in which the sharp edge is interrupted by the haptic base.[@b26-opth-7-1661],[@b27-opth-7-1661] It therefore appears that a sharp posterior edge is a more critical factor in protecting against PCO than whether an IOL is of one-piece or three-piece design.

In addition to beneficial preventive effects on PCO development and LPC requirement, sharp IOL-edge profiles have been associated with increased troublesome glare and photic phenomena. Light rays entering the eye and refracted by the posterior surface of round-edged IOLs are dispersed over a relatively large retinal area, whereas sharper-edged IOLs cause refracted light to be concentrated in a crescent-like distribution on the peripheral retina.[@b28-opth-7-1661] Glare phenomena induced by the sharp edges of implanted IOLs settle with time in the majority, but a small proportion of patients may experience intractable symptoms and require IOL explantation.[@b29-opth-7-1661] Texturing the IOL edge is effective in reducing subjective photic symptoms postoperatively,[@b30-opth-7-1661] although IOL-edge profiles act in combination with other IOL characteristics in glare formation, and modern IOL designs are associated with reduced glare and spherical aberrations overall.[@b31-opth-7-1661]

The favorable results of the single piece AcrySof IOL in our study cannot be fully explained by the edge design. It is possible that whilst a sharp square edge is important for inducing a capsular bend to prevent LEC migration, there may be a threshold degree of edge sharpness beyond which no further mechanical benefit is conferred, and that once an appropriate degree of contact inhibition is induced by a sharp square edge, other factors may come into play to explain variable PCO rates with different IOLs.

IOL material is important in preventing PCO, and acrylic IOLs consistently perform better than other materials.[@b32-opth-7-1661]--[@b34-opth-7-1661] The advantageous effect of acrylic has been attributed to its bioadhesive properties; tight adherence of the IOL surface to the capsular bag may help minimize the space available for proliferation and migration of LECs.[@b35-opth-7-1661],[@b36-opth-7-1661] All three IOLs assessed in this study were hydrophobic acrylic lenses, although the exact formulation of IOL biomaterial does vary between manufacturers ([Table 1](#t1-opth-7-1661){ref-type="table"}).[@b37-opth-7-1661] Subtle variations in biomaterial composition, the blue-light-filtering chromophores, or the IOL-manufacturing process may contribute to the likelihood of LEC migration. There is no clear evidence linking the blue-light-filtering chromophore to PCO development, although a small study in children implanted with either the tinted or nontinted version of an AcrySof IOL reported a slight increase in transient intraocular inflammation in the tinted IOL group, but no differences in long-term inflammatory sequelae or PCO rates.[@b38-opth-7-1661] Further studies looking specifically at the effect of blue-blocking chromophores on PCO development may help to resolve this issue further.

Two main subtypes of PCO have been described, with "pearl" and "fibrous" forms thought to result from the proliferation of different LEC subpopulations.[@b39-opth-7-1661] Pearl-type PCO is reportedly associated with worse CDVA and contrast sensitivity than the fibrous type, and LPC is effective at improving both these parameters,[@b40-opth-7-1661] although different PCO subtypes may require variable degrees of laser energy for effective LPC.[@b41-opth-7-1661] We cannot report whether different subtypes of PCO were associated with the different IOLs in this study, due to the retrospective nature of the data collection and the focus on LPC rates rather than anatomical details of PCO. Laser-energy requirement for LPC was not significantly different between our IOL groups ([Table 3](#t3-opth-7-1661){ref-type="table"}).

This study helps validate the alteration in the polishing process of the Hoya IOLs in order to sharpen the edge of the posterior optic surface as an effective strategy in reducing the requirement for LPC. However, we acknowledge several limitations with the study. As a retrospective analysis, study end points were not defined prior to any intervention. The observation that patient ages were similar in all three groups and that there were no significant differences in CDVA between groups at the time of LPC suggests no considerable bias toward any one of the IOLs. However, the relatively small number of patients in each group undergoing LPC means that statistical tests may be underpowered to detect a significant difference between groups in some parameters, so intergroup differences cannot be ruled out.

Analysis of LPC rates is an indirect measure of PCO, as selection for laser treatment is largely subjective based on patient symptoms, coupled with the identification of PCO signs on slit-lamp examination. Such an indirect marker for PCO is less accurate than formal analysis of the degree of capsular opacity, but it does provide a functional measure of the development of PCO, and the same limitation is applied to all groups under investigation. Other studies comparing IOL performance include those reporting either LPC rates only,[@b5-opth-7-1661],[@b26-opth-7-1661],[@b42-opth-7-1661] qualitative/quantitative measures of PCO,[@b7-opth-7-1661],[@b20-opth-7-1661],[@b24-opth-7-1661],[@b27-opth-7-1661] or combinations of both.[@b9-opth-7-1661],[@b16-opth-7-1661]

The relationship between IOL and anterior capsule was not specifically investigated. Surgery aimed for a large rhexis, with CCC just within the optic diameter, although inevitably there would be some variation in this. The majority of patients were operated on by a single consultant (AS), although some patients included in the analysis had their surgery performed by different trainee surgeons, albeit under direct supervision and according to the same approach described. Therefore, surgical technique may also contribute in part to our observed capsulotomy rates. Patients with coexistent ocular pathology may be less likely to be symptomatic from the development of PCO, and therefore may not progress to LPC, despite a degree of PCO that other patients may find troublesome enough to warrant intervention. Finally, our data are limited to 2 years postoperatively, which may be inadequate to validate LPC requirement in the long term, but this duration is commonly used to report IOL performance after cataract surgery.[@b26-opth-7-1661],[@b27-opth-7-1661],[@b43-opth-7-1661]

Conclusions
===========

Our results suggest that IOL-edge microstructure may contribute to reducing LPC rates following cataract surgery, and indicate the first demonstration of reduced LPC requirement for Hoya IOLs after a change in manufacturing process. However, variations in IOL-material composition may also play a role in determining susceptibility to PCO development independent of edge sharpness.

This work was originally presented at the Congress of the European Society of Cataract and Refractive Surgeons in Milan, Italy (September 8--12, 2012).
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![Neodymium-doped yttrium aluminum garnet laser posterior capsulotomy rates by intraocular lens (IOL) at 2 years postoperatively.\
**Notes**: \**P* \< 0.05; \*\**P* \< 0.01; Chi-squared test.](opth-7-1661Fig1){#f1-opth-7-1661}

![Graphical representation of the assessment of intraocular lens (IOL)-edge sharpness, based on measurement of the area deviating from a perfect square on electron photomicrographs (see text). in these stylized IOLs drawn in section, IOL1 has a smaller area measurement (AM1) than IOL2 (AM2), and therefore has a squarer edge.](opth-7-1661Fig2){#f2-opth-7-1661}

###### 

Characteristics of intraocular lenses (IOLs) used[@b4-opth-7-1661],[@b37-opth-7-1661]

  Hoya FY60AD                                                       Hoya PY60AD                AcrySof SN60WF
  ----------------------------------------------------------------- -------------------------- -------------------------------------
  IOL design                                                                                   
   Three-piece                                                      Three-piece                One-piece
   monofocal                                                        monofocal                  monofocal
   Aspheric,                                                        Aspheric,                  Aspheric,
   6 mm optic                                                       6 mm optic                 6 mm optic
  Posterior square-edge structure                                                              
   Continuous 360°                                                  Continuous 360°            Interrupted at optichaptic junction
  Edge sharpness (area-measurement deviation from perfect square)                              
   329.7 μm^2^                                                      39.1 μm^2^                 100.1 μm^2^
  IOL material                                                                                 
   Hydrophobic acrylic                                              Hydrophobic acrylic        Hydrophobic acrylic
   Phenylethyl methacrylate                                         Phenylethyl methacrylate   Phenylethyl methacrylate
   *N*-butylacrylate                                                *N*-butylacrylate          Phenylethyl acrylate
   Fluoroalkyl methacrylate                                         Fluoroalkyl methacrylate   Butanediol diacrylate
   Blue blocking                                                    Blue blocking              Blue blocking

###### 

Neodymium-doped yttrium aluminum garnet (Nd: YAG) laser capsulotomy rates by intraocular lens at 2 years postoperatively

                    Hoya FY60AD                                                            Hoya PY60AD                                                             AcrySof SN60WF
  ----------------- ------------- -------------------------------------------------------- ------------- --------------------------------------------------------- ----------------
  Implanted         315                                                                    254                                                                     696
  Nd: YAG LPC (%)   28 (8.9)                                                               11 (4.3)                                                                10 (1.4)
                                  *P* = 0.03[\*](#tfn1-opth-7-1661){ref-type="table-fn"}                 *P* = 0.007[\*](#tfn1-opth-7-1661){ref-type="table-fn"}   

**Note:**

Chi-squared test.

**Abbreviation**: LPC, laser posterior capsulotomy.

###### 

Comparison between IOL groups for patient age, duration between primary surgery and LPC, CDVA at presentation for LPC and laser energy delivered. Data presented are mean ± SD for all variables and range where indicated. \*analysis of variance (ANOVA) without *post-hoc* comparison.

                                             Hoya FY60AD   Hoya PY60AD    AcrySof SN60WF   *P*[\*](#tfn3-opth-7-1661){ref-type="table-fn"}
  ------------------------------------------ ------------- -------------- ---------------- -------------------------------------------------
  Patient age (years)                        72.3 ± 9.1    70.7 ± 8.5     74.2 ± 8.1       0.67
   Range                                     52--88        64--85         59--88           
  Duration to laser after surgery (months)   15.8 ± 4.6    17.2 ± 4.3     17.1 ± 3.1       0.56
   Range                                     8--24         10--23         13--22           
  CDVA at LPC (logMAR)                       0.43 ± 0.47   0.45 ± 0.24    0.31 ± 0.27      0.66
  Laser energy delivered (mJ)                68.4 ± 43.8   55.2 ± 22.34   62.9 ± 43.6      0.65

**Abbreviations**: CDVA, corrected distance visual acuity; LPC, laser posterior capsulotomy; logMAR, logarithm of minimum angle of resolution; IOL, intraocular lens; SD, standard deviation.
